In our Swiss Venture Capital Report Update you will find the results for the first half year 2024 plus the results on a survey among 100 Swiss investors which provides an outlook for the coming 12 ...

In our Swiss Venture Capital Report Update you will find the results for the first half year 2024 plus the results on a survey among 100 Swiss investors which provides an outlook for the coming 12 ...

Durant ce STARTIMPULSE nous allons nous adresser à tous les entrepreneurs qui souhaitent se développer à l’international au travers du e-commerce. Nous aborderons des sujets clés tels que la création ...

Autism spectrum disorders (ASD) reflect a critical gap in medical care, often involving challenges in social communication, with limited treatments available for core symptoms. A key barrier to ...

Experienced managers and prominent investors are joining Swiss start-ups. As a result, companies’ networks are becoming ever denser.

Marcel Aumer, CEO, VRP und Co-Founder der FlexBase Group, rechnet trotz der Projektneuauflage nicht mit einer Verzögerung des ambitionierten Zeitplans. Der Baustart ist für Frühling 2025 geplant. Als ...

Mabylon AG is a Schlieren-based biotechnology company at the forefront of human-derived antibody research, with a primary focus on allergies, neurological and inflammatory disorders. The company has ...

Unlike traditional aligners, which often cause oral hygiene problems such as bacteria build-up, bad breath (halitosis) or cavities, Actival incorporates CSEM's patented 3D-printed microchannel ...

PeriVision is rapidly gaining ground thanks to key distribution agreements in the Swiss, Liechtenstein and Brazilian markets. In addition to new strategic support from Innosuisse, the spin-off from ...